1. Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i4-i11. doi: 10.1093/rheumatology/kex453. PMID: 29272515; PMCID: PMC5850858.
2. Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021;42:2745– 2760. doi: 10.1093/eurheartj/ehab221
3. Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL. Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018 Feb;178(2):350-356. doi: 10.1111/bjd.15896. Epub 2018 Jan 3. PMID: 28832953; PMCID: PMC5812812.
4. Esatoglu SN, Hatemi G. Update on the treatment of Behcet’s syndrome. Intern Emerg Med. 2019;14:661–675. doi: 10.1007/s11739-019-02035-1
5. Opstal TSJ, Thompson P, Cornel JH. Colchicine in Acute Coronary Syndrome: When to Commence?. American College of Cardiology. 2021. https://www.acc.org/latest-in-cardiology/articles/2021/09/15/13/23/colchicine-in-acute-coronary-syndrome
6. Adler Y, Charron P, Imazio M, Badano L, Barn-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–2964. doi: 10.1093/eurheartj/ehv318
7. González L, Bulnes JF, Orellana MP, Muñoz Venturelli P, Martínez Rodriguez G. The Role of Colchicine in Atherosclerosis: From Bench to Bedside. Pharmaceutics. 2022 Jul 1;14(7):1395. doi: 10.3390/pharmaceutics14071395. PMID: 35890291; PMCID: PMC9323936.
8. Defetereos SG, Beerkens FJ, Shah Binita, et al. Colchicine in Cardiovascular Disease: In-Depth Review. Circulation. 2022;145:61–78. DOI: 10.1161/CIRCULATIONAHA.121.056171
9. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131. doi: 10.1056/ NEJMoa1707914
10. Rouibille F, Tardif JC. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease. Circulation. 2020;142:1901–1904. DOI: 10.1161/CIRCULATIONAHA.120.051240
11. Meurin P, Lelay-Kubas S, Pierre B, Pereira H, Pavy B, Iliou MC, Bussi.re JL, Weber H, Beugin JP, Farrokhi T, et al; French Society of Cardiology. Colchicine for postoperative pericardial effusion: a multicentre, double blind, randomised controlled trial. Heart. 2015;101:1711–1716. doi: 10.1136/heartjnl-2015-307827.
12. Yao C, Veleva T, Scott L Jr, Cao S, Li L, Chen G, Jeyabal P, Pan X, Alsina KM, Abu-Taha I Dr, et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation. 2018;138:2227–2242. doi: 10.1161/ CIRCULATIONAHA .118.035202
13. Varghese B, Feldman DI, Chew C, Valilis E, Blumenthal RS, Sharma G, Calkins H. Inflammation, atrial fibrillation, and the potential role for colchicine therapy. Heart Rhythm O2. 2021;2:298–303. doi: 10.1016/j.hroo.2021.03.011
14. Lee JZ, Singh N, Howe CL, Low SW, Huang JJ, Ortega G, Lee KS, Pandit A. Colchicine for prevention of post-operative atrial fibrillation: a meta-analysis. JACC Clin Electrophysiol. 2016;2:78–85. doi: 10.1016/j.jacep.2015.09.016
15. Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Kaoukis A, Raisakis K, Bouras G, Angelidis C, Theodorakis A, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012;60:1790–1796. doi: 10.1016/j.jacc.2012.07.031
16. Deftereos S, Giannopoulos G, Efremidis M, Kossyvakis C, Katsivas A, Panagopoulou V, Papadimitriou C, Karageorgiou S, Doudoumis K, Raisakis K, et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014;11:620–628. doi: 10.1016/j.hrthm.2014.02.002
17. Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61:404–410. doi: 10.1016/j.jacc.2012.10.027
18. Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, et al; LoDoCo2 Trial Investigators. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838–1847. doi: 10.1056/NEJMoa2021372
19. Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, Sriamareswaran R, Htun NM, Wilson W, Stub D, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS Randomized Clinical Trial. Circulation. 2020;142:1890–1900. doi: 10.1161 /CIRCULATIONAHA.120.050771
20. Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, IvanesF, Dubreuil O, Biere L, Hayek A, et al. Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation. 2021;144:859–869. doi:10.1161/CIRCULATIONAHA.121.056177
21. Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497–2505. doi: 10.1056/NEJMoa1912388
22. Masson W Lobo M, Molinero G, masson G, lavalle-Cobo A. Role of Colchicine in Stroke Prevention: An Updated Meta-analysis. J Stroke Cerebrovasc Dis. 2020;29(5):104756. Doi: 10.1016 /j.jstroke cerebrovasdisc.2020.104756.
23. Katsanos AH et al. An Updated Meta-analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease.J Clin Med.2021;10(14):3110. https://doi.org/10.3390/jcm10143110.
24. Goh CXY, et al. The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis. J Thromb Thrombolysis.2022;54(1): 183-190. Doi: 10.1007/s11239-022-02659-9
25. Yeh JJ, Kuo Il, Yip HT, et al. Effects of colchicine use on ischemic and hemorrhagic stroke risk in diabetic patients with and without gout. Sci Rep.2022;12:9195. https://doi.org/10.1038/s41598-022-13133-0.
26. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, et al. 2017 HRS/EHRA/ECAS/APHRS/ SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace. 2018;20:157–208. doi: 10.1093/europace/eux275